Oxidative Stress and Inflammation in Heart Failure

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: closed (31 January 2026) | Viewed by 1640

Special Issue Editor


E-Mail Website
Guest Editor
Heart and Vascular Theme, Karolinska University Hospital, S-171 76 Stockholm, Sweden
Interests: heart failure; heart failure with preserved ejection fraction; microvascular inflammation; microvascular dysfuncrion; oxidative stress; endothelial dysfunction; proteomics; metabolomics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The pathophysiological mechanisms underlying cardiomyopathies and the development of heart failure are closely associated with microvascular endothelial inflammation and oxidative stress. These exist both in heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). HFrEF syndrome is primarily driven by neurohormonal activation, and the subsequent development of systemic inflammation is mainly a consequence. In contrast, in HFpEF, the multiplicity of phenotypes suggests a different underlying pathophysiology, with comorbidity-driven global inflammation as a disease driver. Multiple comorbidities result in increased reactive oxygen species (ROS) production and reduced nitric oxide (NO) availability, leading to endothelial and microvascular dysfunction, which causes the stiffening of cardiomyocytes and increased collagen deposition, with the development of left-ventricular concentric remodelling and mainly diastolic dysfunction.

HFpEF and HFrEF are both associated with an abnormal energy metabolism and the increased production of ROS, affecting fatty acid (FA) beta-oxidation. A shift in energy metabolism is a hallmark of heart failure and varies with the progression of the disease. As heart failure develops, FA oxidation, dominating the normal metabolic state in cardiomyocytes, decreases and glucose metabolism increases, possibly due to impaired mitochondrial function. In end-stage heart failure, insulin resistance develops in the myocardium, glucose oxidation decreases, and ketone bodies and lactate compete as energy substrates, resulting in a shift in energy metabolism, regardless of the presence of diabetes.

The role of oxidative stress in the development of cardiomyopathies and energy metabolism in the myocardium is intriguing and may represent a future treatment target. We invite you to contribute to this Special Issue with research findings or a literature review. Our aim is to explore the role of oxidative stress in cardiomyopathies and the development of cardiac dysfunction.

Dr. Camilla Hage
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heart failure
  • oxidative stress
  • HFrEF
  • HFpEF
  • reactive oxygen species
  • nitric oxide
  • cardiomyocytes
  • cardiomyopathies
  • cardiac dysfunction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 553 KB  
Communication
Oxidative Stress Related to Mechanical Heart Valves: A Pilot Cross-Sectional Study
by Ilaria Maria Palumbo, Arianna Pannunzio, Danilo Menichelli, Vittoria Cammisotto, Valentina Castellani, Simona Bartimoccia, Emanuele Valeriani, Vito Maria Daniele Cormaci, Daniele Pastori and Pasquale Pignatelli
Antioxidants 2025, 14(10), 1264; https://doi.org/10.3390/antiox14101264 - 20 Oct 2025
Cited by 1 | Viewed by 1160
Abstract
Background: Valvular heart disease remains a major global health issue, with mechanical prosthetic heart valves (MPHVs) widely used in surgical valve replacement. However, these devices carry a risk of thrombosis, particularly in the mitral position. Several mechanisms may be involved in this risk, [...] Read more.
Background: Valvular heart disease remains a major global health issue, with mechanical prosthetic heart valves (MPHVs) widely used in surgical valve replacement. However, these devices carry a risk of thrombosis, particularly in the mitral position. Several mechanisms may be involved in this risk, but the role of oxidative stress (OxS) remains unclear. Our aim was to assess the relationship between OxS impairment and platelet activation. Methods: We analyzed data from a pilot, observational, monocentric study conducted at our anticoagulation clinic at Sapienza University of Rome, involving adult patients with MPHVs (aortic or mitral) on vitamin K antagonist therapy, enrolled between June and September 2024. Clinical data and blood samples were collected to evaluate markers of NOX2-mediated OxS (sNOX2-dp, H2O2) and platelet activation (sCD40L) using ELISA-based assays. Results: Our cohort included 30 patients with mitral MPHVs and 30 patients with aortic MPHVs (46.7% males, 53.3% females). Serum sNOX2-dp and H2O2 were significantly higher in patients with mitral MPHVs (28.69 [25.08–33.18] vs. 24.27 [17.30–26.41] pg/mL, p = 0.001, and 22.94 [15.79–27.33] vs. 16.73 [12.50–20.87] µM, p = 0.013, respectively) compared with aortic MPHV patients. sCD40L was significantly elevated in mitral versus aortic MPHVs (5.61 [3.69–6.89] vs. 3.65 [2.14–5.54] ng/mL, p = 0.009). Spearman’s correlation analysis showed a significant correlation between sNOX2-dp levels and sCD40L in both groups (mitral MPHVs: rs = 0.521, p = 0.003; aortic MPHVs: rs = 0.443, p = 0.014). Conclusions: Mitral MPHVs are associated with heightened OxS and platelet activation compared to aortic MPHVs. These findings may help explain the higher thrombotic risk observed with mitral valves and support differential management strategies. Full article
(This article belongs to the Special Issue Oxidative Stress and Inflammation in Heart Failure)
Show Figures

Figure 1

Back to TopTop